Since modulation of the kinase activity of ERK1/2 and Akt has been reported to play an important role in the tumorigenicity of glioma cells [14]–[16], we performed western blot analysis aimed at examining the effect of CBD on the phosphorylation status of these two kinases. This evidence concerns the gene MAPK3 and central nervous system cancer.